News

Most physicians and many specialists have limited understanding of clinical trial data and research findings presented in prescription drug promotional materials for professional audiences.

Cancer vaccine-based immunotherapy may help overcome the resistance of certain tumors to immune checkpoint inhibitors, while immune checkpoint inhibitors may enhance the efficacy of cancer vaccine therapies.

Vienna joins growing list of bidders to land Europe's drug regulator; Amsterdam the early favorite?

PV experts face new challenges as focus in field moves toward acting on real-world evidence insights.  

Q&A explores the evolution of the patient-centric supply chain and how it's poised to impact the clinical trials landscape.

Supply chain strategies require a close look at the regulatory factors and the drug import hurdles and hopes in the region.

How a single-source temperature management strategy can support a drug’s quality and integrity in transit-a process as important as the destination.

Outlining a decision-making framework that integrates real-world signals with supply planning techniques to reduce risk and avoid potential interruptions.

Learn to partner effectively in the era of collaboration, where the benefits gained will outweigh the challenges if approached correctly

The key to moving legacy systems-electronic or paper-to the cloud: Do it in doses-and learn from those who went before.

With recent reports indicating that organizations do not have a way of tracking and managing the timeliness of data entry or of site payments, The Metrics Champion Consortium wanted to see if there were opportunities to align incentives in the industry so that both sites and sponsors can achieve their goals with positive impact on clinical trials and patients.

Because of the growing rate of voice assistant applications, such as Alexa, healthcare and life sciences organizations are beginning to design a range of scenarios for deploying these voice assistant platforms in the clinical trial setting.